ARCHIVES

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

This article is from The Cancer Letter archive.

Vol. 18 No. 25 | June 19, 1992

Download PDF Visit The Full Archive

Related Articles

New Drugs Improve Outlook For Bone Marrow Cancer

March 31, 2006

ECOG, ACRIN Agree To Join; NCI’s Goal Of Four Adult Groups Is One Merger Away

March 18, 2011

GM Downsizes “Nobel Prize” For Cancer; Bristol Ends Medical Research Grants and Awards Program.

June 23, 2006

In Turnaround, NCAB To Advise Screening Mammography for Women In Their Forties

March 28, 1997

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002

Phase III Kyprolis Trial Fails OS Primary Endpoint

August 29, 2014